Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
Zoetis Stock Quote

Zoetis (NYSE: ZTS)

$169.58
(-1.0%)
-$1.74
Price as of June 14, 2024, 1:38 p.m. ET

Zoetis Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ZTS +4.43% +60.21% +9.88% +500%
S&P +24.27% +88.22% +13.48% +259%

Zoetis Company Info

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.

News & Analysis

The Fool has written over 100 articles on Zoetis.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.